Functional Outcomes After Localized Prostate Cancer TreatmentBashir Al Hussein Al Awamlh, Daniel A. Barocas, Christopher J.D. Wallis et al.|JAMA|2024Cited by 97
Use of Active Surveillance vs Definitive Treatment Among Men With Low- and Favorable Intermediate–Risk Prostate Cancer in the US Between 2010 and 2018Bashir Al Hussein Al Awamlh, Jonathan E. Shoag, Daniel A. Barocas et al.|JAMA Internal Medicine|2023Cited by 29
Projected Savings for Generic Oncology Drugs Purchased via Mark Cuban Cost Plus Drug Company Versus in MedicareBrian D. Cortese, Ruchika Talwar, Stacie B. Dusetzina et al.|Journal of Clinical Oncology|2023Cited by 18
Implementation of a comprehensive prehabilitation program for patients undergoing radical cystectomyWoodson Smelser, Sam S. Chang, Jacob E. Tallman et al.|Urologic Oncology Seminars and Original Investigations|2022Cited by 15
The lived experience of prostate cancer: 10-year survivor perspectives following contemporary treatment of localized prostate cancerBashir Al Hussein Al Awamlh, Laura M. Beskow, Christopher J.D. Wallis et al.|Journal of Cancer Survivorship|2023Cited by 12